BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6531018)

  • 1. Cutaneous phototoxicity due to psoralens.
    Gange RW; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in topical and systemic reactivity of psoralens: determinations of epidermal and serum levels.
    Kornhauser A; Wamer WG; Giles AL
    Natl Cancer Inst Monogr; 1984 Dec; 66():97-101. PubMed ID: 6531046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of psoralen photosensitization reactions.
    Pathak MA
    Natl Cancer Inst Monogr; 1984 Dec; 66():41-6. PubMed ID: 6531038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time.
    Meffert H; Andersen KE; Sönnichsen N
    Photodermatol; 1984 Aug; 1(4):191-4. PubMed ID: 6531293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
    Bech-Thomsen N; Angelo HR; Wulf HC
    Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of temperature on the cutaneous phototoxic reaction to 8-methoxypsoralen in human skin.
    Youn JI; Maytum D; Gange RW
    Photodermatol; 1987 Dec; 4(6):277-80. PubMed ID: 3444754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
    Koulu L; Jansén CT
    Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar.
    Pathak MA; Joshi PC
    J Invest Dermatol; 1983 Jun; 80 Suppl():66s-74s. PubMed ID: 6854058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoralen-containing sunscreen induces phototoxicity and epidermal ornithine decarboxylase activity.
    Walter JF; Gange RW; Mendelson IR
    J Am Acad Dermatol; 1982 Jun; 6(6):1022-7. PubMed ID: 7096664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    Wolff K; Hönigsmann H
    Natl Cancer Inst Monogr; 1984 Dec; 66():159-64. PubMed ID: 6531023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
    Ljunggren B; Bjellerup M; Carter DM
    J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanisms of action of phototherapy in the treatment of the most common dermatoses.
    Bulat V; Situm M; Dediol I; Ljubicić I; Bradić L
    Coll Antropol; 2011 Sep; 35 Suppl 2():147-51. PubMed ID: 22220423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic alterations of psoralen- and longwave ultraviolet radiation-exposed skin.
    Harrist TJ; Gonzalez E
    Natl Cancer Inst Monogr; 1984 Dec; 66():197-204. PubMed ID: 6531029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of psoralens after oral administration: considerations and conclusions.
    Brickl R; Schmid J; Koss FW
    Natl Cancer Inst Monogr; 1984 Dec; 66():63-7. PubMed ID: 6531040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema resulting from suberythemogenic doses of ultraviolet radiation and methotrexate.
    LeVine MJ
    Arch Dermatol; 1981 Oct; 117(10):656-8. PubMed ID: 7283458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical methoxsalen administration and sunlamp fluorescent irradiation in psoriasis.
    Petrozzi JW; Barton JO; Kligman A; de los Reyes O
    Arch Dermatol; 1979 Apr; 115(4):436-9. PubMed ID: 434863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing methoxsalen phototoxicity in vitiliginous skin.
    Arora SK; Willis I
    Arch Dermatol; 1976 Mar; 112(3):327-32. PubMed ID: 1259445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.